Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nippon Chemiphar Parts Ways With Ranbaxy; Takes Over Generics Venture

This article was originally published in PharmAsia News

Executive Summary

Tokyo-based Nippon Chemiphar Dec. 8 announced a dissolution of its partnership with India's Ranbaxy Laboratories. A generic drug joint venture established by the two will become a Nippon Chemiphar wholly owned subsidiary
Advertisement

Related Content

Teva-Kowa Accelerates Japanese Generic Expansion With Taisho Acquisition
Teva-Kowa Accelerates Japanese Generic Expansion With Taisho Acquisition
Pfizer Leaps Into Japanese Generics Foray; Aims For 100 Generic Products By 2011
Sandoz Launches Japan's First Biosimilar; Sees Huge Market Potential In Japan
As Daiichi Sankyo Takes Over Ranbaxy Reins, Japan’s Nippon Chemiphar May Exit JV
As Daiichi Sankyo Takes Over Ranbaxy Reins, Japan’s Nippon Chemiphar May Exit JV
Advertisement
UsernamePublicRestriction

Register

SC070564

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel